Alivus Life Sciences Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Sep-24 | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 |
|---|---|---|---|---|---|---|---|---|
| 507 | 642 | 650 | 602 | 588 | 673 | 689 | 640 | |
| 9 | 10 | 10 | 9 | 15 | 14 | 23 | 22 | |
| 388 | 467 | 468 | 448 | 429 | 463 | 496 | 451 | |
| 239 | 288 | 280 | 269 | 289 | 276 | 229 | 253 | |
| −14 | −2 | 2 | 1 | −40 | 0.06 | 42 | 2 | |
| 62 | 66 | 67 | 62 | 66 | 66 | 78 | 68 | |
| 0.34 | 0.46 | 1 | 1 | 1 | 1 | 1 | 1 | |
| 15 | 15 | 16 | 17 | 18 | 20 | 20 | 21 | |
| 85 | 101 | 102 | 98 | 93 | 99 | 126 | 105 | |
| 143 | 201 | 209 | 181 | 194 | 220 | 237 | 234 | |
| 128 | 186 | 193 | 164 | 175 | 200 | 217 | 214 | |
| — | — | — | — | — | −26 | — | — | |
| 127 | 185 | 191 | 163 | 174 | 198 | 216 | 212 | |
| 32 | 48 | 49 | 41 | 44 | 48 | 53 | 52 | |
| 95 | 137 | 142 | 122 | 130 | 150 | 163 | 160 | |
| Financial ratios | ||||||||
| 28.19% | 31.28% | 32.10% | 30.12% | 32.98% | 32.63% | 34.44% | 36.56% | |
| 18.81% | 21.34% | 21.84% | 20.19% | 22.11% | 22.33% | 23.60% | 25.00% | |
| 7.78 | 11.18 | 11.57 | 9.91 | 10.60 | 12.25 | 13.23 | 13.04 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.